ERBB2 and neoplasm: The Australian HER2-Low Breast Cancer Concordance Study, comprising 9 expert breast pathologists, analysed WSI of 60 HER2 stained tumours stained by 4B5 assay from 3 lobotomies and mainly originally scored as IHC 0 or 1+.